Celularity Inc.
General ticker "CELU" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $46.7M (TTM average)
Celularity Inc. does not follow the US Stock Market performance with the rate: -33.4%.
Estimated limits based on current volatility of 4.0%: low 0.76$, high 0.83$
Factors to consider:
- Total employees count: 116 (-16.5%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Insufficient capital, Going concern doubt, Regulatory and compliance, Manufacturing risks, Clinical trial failure
- Current price 41.8% below estimated low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.29$, 4.60$]
- 2025-12-31 to 2026-12-31 estimated range: [1.34$, 4.62$]
Financial Metrics affecting the CELU estimates:
- Positive: with PPE of 1.2 at the end of fiscal year the price was low
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 1.06 > -0.60
- Negative: Inventory ratio change, % of 4.95 > 0.80
- Negative: Industry earnings per price (median), % of -15.38 <= 0
Short-term CELU quotes
Long-term CELU plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $22.77MM | $54.22MM | $26.55MM |
| Operating Expenses | $215.06MM | $92.58MM | $87.86MM |
| Operating Income | $-192.29MM | $-38.36MM | $-61.31MM |
| Non-Operating Income | $-4.00MM | $-19.53MM | $-30.41MM |
| Interest Expense | $0.00MM | $0.00MM | $6.75MM |
| R&D Expense | $30.46MM | $17.39MM | $15.03MM |
| Income(Loss) | $-196.28MM | $-57.89MM | $-91.71MM |
| Taxes | $0.01MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-196.29MM | $-57.89MM | $-91.80MM |
| Stockholders Equity | $40.96MM | $8.84MM | $-38.06MM |
| Assets | $143.89MM | $132.68MM | $107.33MM |
| Operating Cash Flow | $-38.69MM | $-6.40MM | $-13.25MM |
| Capital expenditure | $4.05MM | $0.16MM | $0.00MM |
| Investing Cash Flow | $-4.05MM | $0.51MM | $0.00MM |
| Financing Cash Flow | $24.09MM | $6.70MM | $18.65MM |
| Earnings Per Share** | $-11.02 | $-2.64 | $-3.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.